Article citationsMore>>

Flynn, J.L., Goldstein, M.M., Chan, J., Triebold, K.J., Pfeffer, K., Lowenstein, C.J., et al. (1995) Tumor Necrosis Factor-Alpha Is Required in the Protective Immune Response against Mycobacterium tuberculosis in Mice. Immunity, 2, 561-572. http://dx.doi.org/10.1016/1074-7613(95)90001-2

has been cited by the following article:

• TITLE: Tuberculous Peritonitis Mimicking Malignancy during Adalimumab Therapy in a Patient with Rheumatoid Arthritis

  AUTHORS: Refik Demirtunç, Uğur Özensoy, Kadir Kayataş, Fügen Vardar Aker

  KEYWORDS: Adalimumab, Rheumatoid Arthritis, Tuberculous Peritonitis

  JOURNAL NAME: Journal of Tuberculosis Research, Vol.3 No.3, August 27, 2015

  ABSTRACT: We present a case of tuberculous peritonitis in a 46-year-old woman with rheumatoid arthritis treated with adalimumab, and we review the association between anti-tumour necrosis factor therapy and tuberculosis. This case illustrates that tuberculosis can develop with atypical clinic and uncertain laboratory findings and may mimic malignancies during adalimumab therapy.